But did that study show more approvals on the first resub, the second, or both? Perhaps there isn't a significant increase in the number of approvals upon the second resub, and therefore it's not worth the additional work/cost on everyone's part?

Meg
--
Margaret Bouvier, Ph.D.
Medical and Science
Writing, Editing, Advising
Grants * Publications * Communications * Policy
xxxxxx@comcast.net * 413.230.6523

> what's weird is NIH's own study showed that resubmissions result in more
> approvals, esp. for clinical studies.

> puzzling.
>
>
>
>
>
> -----Original Message-----
> From: Kiss, Helen G. Dr. <xxxxxx@MUOHIO.EDU>
> To: xxxxxx@hrinet.org
> Sent: Wed, 8 Oct 2008 11:55 am
> Subject: Re: [RESADM-L] New NIH Policy on Resubmission (Amended) Applications
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
> The NIH link is:
> http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-003.html
>
>
>
>
>
>
> Helen G. Kiss, Ph.D.
>
>
>
> Assistant Director & Information Coordinator
>
>
>
> Miami University
>
>
>
> Office for the Advancement of Research & Scholarship,
>
>
>
> 102 Roudebush Hall,
>
>
>
> Oxford, OH 45056
>
>
>
> xxxxxx@muohio.edu
>
>
>
> ��
>
>
>
> (P) 513-529-3600
>
>
>
> (F) 513-529-3762
>
>
>
> ��
>
>
>
> The
> mission of the Office for the Advancement of Research & Scholarship (OARS)
> is to encourage, facilitate, and support the Miami University community in its
> effort to obtain external funding for all forms of research, education,
> scholarly, creative, service, and outreach activities.
>
>
>
> ��
>
>
>
>
>
>
> ��
>
>
>
>
>
>
>
>
>
> From: Research
> Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Carolyn
> Elliott-Farino
>
> Sent: Wednesday, October 08, 2008 11:46 AM
>
> To: xxxxxx@hrinet.org
>
> Subject: Re: [RESADM-L] New NIH Policy on Resubmission (Amended)
> Applications
>
>
>
>
>
>
>
>
>
> ��
>
>
>
>
>
>
> Robert,
>
>
>
>
>
>
>
>
>
> ��
>
>
>
>
>
>
>
>
>
> Thanks for the info.
> I was surprised I hadn't seen the notice and I just logged onto to NIH and
> unde
> r their policy notices the latest one listed is NOT-OD-09-002. How did you
> get this one already?
>
>
>
>
>
>
>
>
>
> ��
>
>
>
>
>
>
>
>
>
> Carolyn
>
>
>
> >>> xxxxxx@IUPUI.EDU 10/8/2008 10:42:15 AM >>>
>
>
>
>
>
>
>
>
>
> NIH has revised its
> renewal policy from three strikes to "two strikes and you're out."
>
>
>
> Currently funded projects will be grandfathered to allow three attempts for
> continued funding but they won't accept any -A2 applications after January 7,
> 2011.
>
>
>
> 1st try: R01AA012345-06
>
> 2nd try: R01AA012345-06A1
>
> 3rd try: R01AA012345-06A2 (NLT 7 Jan 11)
>
>
>
> Robert Aull
>
> Indiana University
>
>
>
>
>
> New NIH Policy on Resubmission (Amended) Applications
>
> ----------------------------------------------------------------------------
>
>
>
> Notice Number: NOT-OD-09-003
>
>
>
> Key Dates
>
> Release Date:�� October 8, 2008
>
>
>
> Issued by
>
> National Institutes of Health (NIH), (http://www.nih.gov)
>
>
>
> Purpose
>
>
>
> NIH announces a change in the existing policy on resubmission (amended)
>
> applications (see http://grants.nih.gov/grants/policy/amendedapps.htm).
>
> Beginning with original new applications (i.e., never submitted) and
>
> competing renewal applications submitted for the January 25, 2009 due dates
>
> and beyond, the NIH will accept only a single amendment to the original
>
> application.�� Failure to receive funding after two submissions (i.e., the
>
> original and the single amendment) will mean that the applicant should
>
> substantially re-design the project rather than simply change the application
> in response to previous reviews.�� It is ex
> pected that this policy will lead
> to funding high quality applications earlier, with fewer resubmissions.
>
>
>
> Background
>
>
>
> Following the release of the Peer Review Report that was drafted with
>
> extensive consultation with the external community, Dr. Zerhouni, NIH
>
> Director, established a Peer Review Oversight Committee (PROC) to finalize
>
> the recommendations and begin immediate implementation of those
>
> recommendations.�� Of particular concern was the marked reduction in the
>
> number of awards made in response to original applications.�� An increasing
>
> number of projects were funded only after one or more
> resubmissions.���� In
>
> periods of constricted funding, a greater number of projects require
>
> resubmission, and review committees are more likely to show greater
>
> preference for amended applications.�� These trends have increased the time
>
> from original submission to award and the number of submissions per
>
> investigator. As a result, there has been greater burden placed on applicants
> and reviewers as well as a delay in funding for meritorious science.
>
>
>
> To change this trend and increase the likelihood that meritorious original
>
> applications will be funded, the NIH will decrease the number of amendments
>
> allowed.�� Accordingly, the NIH will begin to phase out second amendment
>
> applications starting with the January 25, 2009 due date. This policy will
>
> increase the numbers of high quality original and first amendments that can
>
> be funded earlier.
>
>
>
> NIH Policy on Resubmission (Amended) Applications
>
>
>
>
> Beginning with applications intended for the January 25, 2009 due date, all
>
> original new applications (i.e., never submitted) and competing renewal
>
> applications will be permitted only a single amendment (A1).�� For this and
>
> subsequent cohorts of original new and competing renewal applications, any
>
> second amendment (A2) will be administratively withdrawn and not accepted for
> review.���� Applicants who fail to receive funding after two
> submissions may resubmit but only if the application is fundamentally revised
> to qualify as new.�� A new application is expected to be substantially different
> in content and scope with more significant differences than are normally
> encountered in an amended application.�� Note that there is no time limit
> for the submission of the original and subsequent A1.
>
>
>
> Original new and competing renewal applications that were submitted prior to
>
> January 25, 2009 will be permitted two amendments (A1 and A2).�� For these
>
> "grandfathered" applications, NIH expects that any A2 will be
> submitted no
>
> later than January 7, 2011, and NIH will not accept A2 applications after
>
> that date.
>
>
>
> This policy applies to all applications, including applications submitted
>
> under the NIH Small Business Innovation Research (SBIR) and Small Business
>
> Technology Transfer (STTR) programs, Career Development Awards, Individual
>
> Fellowships, Institutional Training Grants, Resource Grants, Program
>
> Projects, and Centers.�� Currently no amendments are permitted for
>
> applications received in response to a Request fo
> r Applications (RFA) unless
>
> it is specified in the Funding Opportunity Announcement, in which case only
>
> one amendment will be permitted.�� ations (RFA) unless it is specified in
> the
>
> Funding Opportunity Announcement, in which case only one amendment will be
>
> permitted.
>
>
>
> Inquiries
>
>
>
> Applicants are strongly encouraged to discuss their questions with their NIH
>
> IC contact.�� For additional information or questions, please contact:
>
>
>
> Division of Receipt and Referral
>
> Center for Scientific Review
>
> 6701 Rockledge Drive MSC 7720
>
> Bethesda, MD�� 20892-7720
>
> Voice:�� (301) 435-0715
>
> Fax:�� (301) 480-1987
>
>
>
> Or send an email to xxxxxx@mail.nih.gov.
>
>
>
> Clinicalmail is a service provided by the Association of American Medical
> Colleges
>
>
>
>
>
> ======================================================================
>
> Instructions on how to use the RESADM-L Mailing List, including
>
> subscription information and a web-searchable archive, are available
>
> via our web site at http://www.hrinet.org
> (click on "Listserv Lists")
>
> ======================================================================
>
>
>
>
>
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, incl
> uding subscription
> information and a web-searchable archive, are available via our web site at
> http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
>
>
>
>
>
>
>
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
>
>
>
>
>
>
>
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================